About Michelle Doig
Michelle Doig is a director at BridgeBio Oncology Therapeutics.
Form D filings name Michelle Doig as a director at TheRas.
Michelle Doig reports to the SEC as a director or officer of 3 public companies, including Nuvation Bio (NUVB) and Omega Alpha SPAC (OMEG).
Michelle Doig first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Michelle Doig in the role, so the role may have started earlier or lasted longer.
BI
BridgeBio Oncology Therapeutics, Inc.
Director
2025 · Public company (BBOT)
NI
Nuvation Bio Inc.
Director
2021 · Public company (NUVB)
OS
Omega Alpha SPAC
President and director
2021 · Public company (OMEG)
Key Colleagues at Startups
The people Michelle Doig works with at each company, as listed on that company's latest Form D.
TheRas, Inc. · Form D, May 15, 2024
IE
Idan Elmelech
Executive officer
PB
Pedro Beltran
Executive officer
FM
Frank McCormick
Director
NK
Neil Kumar
Director
EW
Eli Wallace
CEO
RK
Raymond Kelleher
Director